Influence of temperature on the cardiac action of dobutamine and levosimendan in isolated perfused hearts
U Aldenhoff, R Vicenzi-Moser, Martin N. Vicenzi, David Benjamin Konrad, E Schwarzl, Wolfgang G Toller
Abstract
Open-access reader
U Aldenhoff, R Vicenzi-Moser, Martin N. Vicenzi, David Benjamin Konrad, E Schwarzl, Wolfgang G Toller
Abstract
Open-access reader
Inotropic agents (catecholamines or calcium-sensitizers) are frequently used in hypothermic as well as hyperthermic patient conditions. Divergent results from animal experiments raise doubt as to whether they act to the same extent at different body temperatures. Thus, we studied the influence of clinically relevant temperatures on the hemodynamic effects of dobutamine and levosimendan using the Langendorff model of isolated perfused hearts.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Inotropic agents (catecholamines or calcium-sensitizers) are frequently used in hypothermic as well as hyperthermic patient conditions. Divergent results from animal experiments raise doubt as to whether they act to the same extent at different body temperatures. Thus, we studied the influence of clinically relevant temperatures on the hemodynamic effects of dobutamine and levosimendan using the Langendorff model of isolated perfused hearts.
Key concepts: Levosimendan, Dobutamine, Inotrope, Medicine, Cardiology, Hemodynamics, Internal medicine, Intensive care medicine